TMCnet News

NowRx 2021 Momentum - in Revenue, Expanded Services and Service Areas, Equity Raises, and More - Makes It a Healthcare Company to Watch in 2022
[January 20, 2022]

NowRx 2021 Momentum - in Revenue, Expanded Services and Service Areas, Equity Raises, and More - Makes It a Healthcare Company to Watch in 2022


NowRx, a tech-powered pharmacy that provides same-day prescription delivery and telehealth services, today shared a number of milestones demonstrating the momentum achieved in 2021 and why it is a company to watch in 2022.

Thanks to its newest telehealth product as well as existing, proprietary "QuickFill" software, use of intelligent automation and robotics, and expert pharmacy staff -including HIPAA-trained drivers, NowRx has now:

  • Achieved over $25M in annualized revenue as of November;
  • Launched NowRx Telehealth which grew by 1,081% from Q1 to Q3;
  • Announced expansion beyond California and Arizona to Nevada, Washington State, Houston and Colorado (it is about to add four new locations to its existing 8 DEA-licensed micro-fulfillment pharmacies);
  • Raised record amount of equity crowdfunding (Record $20M Series B raise on SeedInvest sold out and in the process of raising a record $73M with $12 already committed); and,
  • Won the SureScripts White Coat Award for highest accuracy in e-prescriptions and patient safety.

According to NowRx CEO Cary Breese, the company's success was also due to its ability to capitalize on several key trends in 2021. "Much has been written about the role of the panemic in accelerating the adoption of telehealth services," said Breese. "Patients seeking to avoid infection got used to virtual visits with their doctors. Why would they want to leave the comfort of home to go stand in line to fill a prescription? This naturally led to increased demand for same-day prescription delivery services."



Breese explained that on-demand prescription delivery became an even more important alternative as traditional brick-and-mortar pharmacies started to withdraw from communities. "Reduced sales, supply chain issues, and staffing shortages led to the closure of retail stores in general and retail pharmacies in particular - CVS recently announced it is shutting down nearly 1,000 locations," said Breese. "But as they leave, we are establishing new micro-fulfillment pharmacies nearby so we can address the needs in these communities for a better pharmacy experience."

In 2022, the company plans to open a number of new locations across the Western part of the US, while significantly expanding the types of diseases that can be treated within its telehealth services. Furthermore, NowRx plans to expand its pharmacy product offerings to include specialty medication and mail-order services as well as a NowRx physician portal which will offer any physician a direct line of visibility and communication into their patients using NowRx. The company expects these additions will have a significantly positive impact on revenue and customer acquisition in 2022.


About NowRx

NowRx is redefining healthcare by providing same day pharmacy delivery and telehealth services. By leveraging customized robotic dispensing, industry leading consumer and driver apps, and QuickFill, a proprietary pharmacy management and logistics system, NowRx can offer same-day end-to-end services, from online prescribing to prescription delivery. This includes telehealth services to prescribe for several conditions, searches for discount coupons, insurance approval, payment assistance, live customer service, and same-day prescription delivery.

To date, NowRx has 8 DEA licensed micro fulfillment pharmacies spread across the San Francisco Bay Area, Orange County, Los Angeles, and Phoenix with more than 35,000 customers and 365,000 prescriptions successfully delivered to date. Additionally, at the time of writing, every single NowRx location boasts a 5-star review rating on Yelp from patients and doctors.

Learn more at www.nowrx.com.


[ Back To TMCnet.com's Homepage ]